Market Value958,473,386
Total Holdings93
File Date2023-02-13
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
GTHX / G1 Therapeutics, Inc.
KRTX / Karuna Therapeutics, Inc.
JAZZ / Jazz Pharmaceuticals plc
REGN / Regeneron Pharmaceuticals, Inc.
EPIX / ESSA Pharma Inc.
VRAY / ViewRay Inc.
SILK / Silk Road Medical, Inc
HUM / Humana Inc.
ABT / Abbott Laboratories
PHR / Phreesia, Inc.
AGL / agilon health, inc.
DHR / Danaher Corporation
NKTR / Nektar Therapeutics
NVST / Envista Holdings Corporation
ABMD / Abiomed Inc.
ESPR / Esperion Therapeutics, Inc.
SGMO / Sangamo Therapeutics, Inc.
HZNP / Horizon Therapeutics Plc
PGNY / Progyny, Inc.
IOVA / Iovance Biotherapeutics, Inc.
HRMY / Harmony Biosciences Holdings, Inc.
RCM / R1 RCM Inc.
OSH / Oak Street Health Inc
VRTX / Vertex Pharmaceuticals Incorporated
NVCR / NovoCure Limited
NKTX / Nkarta, Inc.
MRSN / Mersana Therapeutics, Inc.
RVNC / Revance Therapeutics, Inc.
VEEV / Veeva Systems Inc.
SGEN / Seagen Inc
JNJ / Johnson & Johnson
SWAV / Shockwave Medical, Inc.
EXAS / Exact Sciences Corporation
IQV / IQVIA Holdings Inc.
ALKS / Alkermes plc
TXG / 10x Genomics, Inc.
HCAT / Health Catalyst, Inc.
COO / The Cooper Companies, Inc.
STXS / Stereotaxis, Inc.
RPID / Rapid Micro Biosystems, Inc.
MRTX / Mirati Therapeutics, Inc.
IGMS / IGM Biosciences, Inc.
GH / Guardant Health, Inc.
PHAT / Phathom Pharmaceuticals, Inc.
RIGL / Rigel Pharmaceuticals, Inc.
INSP / Inspire Medical Systems, Inc.
APLS / Apellis Pharmaceuticals, Inc.
TECH / Bio-Techne Corporation
XNCR / Xencor, Inc.
PRVA / Privia Health Group, Inc.
LLY / Eli Lilly and Company
THC / Tenet Healthcare Corporation
TDOC / Teladoc Health, Inc.
ISEE / IVERIC bio Inc
HCA / HCA Healthcare, Inc.
OLK / Olink Holding AB (publ) - Depositary Receipt (Common Stock)
NTLA / Intellia Therapeutics, Inc.
PFE / Pfizer Inc.
ALHC / Alignment Healthcare, Inc.
UNH / UnitedHealth Group Incorporated
RPRX / Royalty Pharma plc
AXNX / Axonics, Inc.
IMGN / ImmunoGen, Inc.
WST / West Pharmaceutical Services, Inc.
ALLO / Allogene Therapeutics, Inc.
MGTX / MeiraGTx Holdings plc
BIIB / Biogen Inc.
BNTX / BioNTech SE - Depositary Receipt (Common Stock)
GILD / Gilead Sciences, Inc.
IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock)
BMRN / BioMarin Pharmaceutical Inc.
ISRG / Intuitive Surgical, Inc.
PODD / Insulet Corporation
TMO / Thermo Fisher Scientific Inc.
EW / Edwards Lifesciences Corporation
RLAY / Relay Therapeutics, Inc.
NUVL / Nuvalent, Inc.
MCK / McKesson Corporation
MDT / Medtronic plc
ELV / Elevance Health, Inc.
NBIX / Neurocrine Biosciences, Inc.
ABBV / AbbVie Inc.
CI / The Cigna Group
NTRA / Natera, Inc.
CVS / CVS Health Corporation
ARVN / Arvinas, Inc.
OM / Outset Medical, Inc.
BSX / Boston Scientific Corporation
DVAX / Dynavax Technologies Corporation
CYTK / Cytokinetics, Incorporated
ITCI / Intra-Cellular Therapies, Inc.
COR / Cencora, Inc.
BDX / Becton, Dickinson and Company
GKOS / Glaukos Corporation
ALNY / Alnylam Pharmaceuticals, Inc.
IONS / Ionis Pharmaceuticals, Inc.
MRK / Merck & Co., Inc.